FI952734A - 2-Amino-6-A-propyyli-amino-4,5,6,7-tetrahydrobentsotiatsolin (Pramipexolin) käyttö lääkeaineena, jolla on antidepressiivinen vaikutus - Google Patents

2-Amino-6-A-propyyli-amino-4,5,6,7-tetrahydrobentsotiatsolin (Pramipexolin) käyttö lääkeaineena, jolla on antidepressiivinen vaikutus Download PDF

Info

Publication number
FI952734A
FI952734A FI952734A FI952734A FI952734A FI 952734 A FI952734 A FI 952734A FI 952734 A FI952734 A FI 952734A FI 952734 A FI952734 A FI 952734A FI 952734 A FI952734 A FI 952734A
Authority
FI
Finland
Prior art keywords
tetrahydrobenzothiazole
pramipexole
propylamino
drug
amino
Prior art date
Application number
FI952734A
Other languages
English (en)
Swedish (sv)
Other versions
FI952734A0 (fi
Inventor
Rudolf Hammer
Joachim Mierau
Erich Lehr
Franco Borsini
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI952734A0 publication Critical patent/FI952734A0/fi
Publication of FI952734A publication Critical patent/FI952734A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FI952734A 1992-12-05 1995-06-05 2-Amino-6-A-propyyli-amino-4,5,6,7-tetrahydrobentsotiatsolin (Pramipexolin) käyttö lääkeaineena, jolla on antidepressiivinen vaikutus FI952734A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
PCT/EP1993/003389 WO1994013287A1 (de) 1992-12-05 1993-12-02 Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung

Publications (2)

Publication Number Publication Date
FI952734A0 FI952734A0 (fi) 1995-06-05
FI952734A true FI952734A (fi) 1995-06-05

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952734A FI952734A (fi) 1992-12-05 1995-06-05 2-Amino-6-A-propyyli-amino-4,5,6,7-tetrahydrobentsotiatsolin (Pramipexolin) käyttö lääkeaineena, jolla on antidepressiivinen vaikutus

Country Status (29)

Country Link
US (1) US6191153B1 (fi)
EP (1) EP0675717B1 (fi)
JP (1) JP3221880B2 (fi)
KR (1) KR100311165B1 (fi)
CN (1) CN1052400C (fi)
AT (1) ATE183091T1 (fi)
AU (1) AU674378B2 (fi)
BG (1) BG62475B1 (fi)
CA (1) CA2150131C (fi)
CZ (1) CZ282679B6 (fi)
DE (2) DE4241013A1 (fi)
DK (1) DK0675717T3 (fi)
ES (1) ES2136725T3 (fi)
FI (1) FI952734A (fi)
GR (1) GR3031521T3 (fi)
HK (1) HK1019003A1 (fi)
HU (1) HU221014B1 (fi)
IL (1) IL107870A (fi)
MX (1) MX9307644A (fi)
NO (1) NO306930B1 (fi)
NZ (1) NZ258876A (fi)
PL (1) PL309282A1 (fi)
RU (1) RU2157685C2 (fi)
SG (1) SG49228A1 (fi)
SK (1) SK281441B6 (fi)
TW (1) TW362973B (fi)
UA (1) UA35604C2 (fi)
WO (1) WO1994013287A1 (fi)
ZA (1) ZA939065B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6001861A (en) 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
CA2301899C (en) * 1998-07-27 2008-11-18 Boehringer Ingelheim Pharma Kg Agent with an antidepressant activity
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
AU7887501A (en) * 2000-07-06 2002-01-21 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
DE102004006808A1 (de) 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
CN101843597A (zh) * 2004-08-13 2010-09-29 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
SI1781260T2 (sl) * 2004-08-13 2014-08-29 Boehringer Ingelheim International Gmbh Tabletna formulacija s podaljšanim sproščanjem, ki vsebuje pramipeksol ali njegovo farmacevtsko sprejemljivo sol, postopek za izdelavo le-te in njena uporaba
US20090042861A1 (en) * 2005-04-04 2009-02-12 Takeda Pharmaceutical Company Limited Prophylactic or Therapeutic Agent for Depression or Anxiety Disorder
US20080262053A1 (en) * 2005-10-18 2008-10-23 Juergen Reess Use of Pramipexole for Treating Moderate to Severe Restless Legs Syndrome (Rls)
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
EP3609495A4 (en) * 2017-04-10 2020-12-02 Chase Therapeutics Corporation NK1 ANTAGONIST COMBINATION AND METHOD OF TREATMENT OF SYNUCLEINOPATHIA
KR20200026920A (ko) 2017-06-30 2020-03-11 체이스 테라퓨틱스 코포레이션 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
JP3221880B2 (ja) 2001-10-22
FI952734A0 (fi) 1995-06-05
IL107870A0 (en) 1994-04-12
HU221014B1 (hu) 2002-07-29
SG49228A1 (en) 1998-05-18
NO952207D0 (no) 1995-06-02
CZ144095A3 (en) 1996-03-13
CN1091635A (zh) 1994-09-07
GR3031521T3 (en) 2000-01-31
KR100311165B1 (ko) 2001-12-28
CA2150131C (en) 2004-09-21
CA2150131A1 (en) 1994-06-23
EP0675717A1 (de) 1995-10-11
US6191153B1 (en) 2001-02-20
NZ258876A (en) 1997-07-27
SK281441B6 (sk) 2001-03-12
IL107870A (en) 1996-12-05
DE4241013A1 (de) 1994-06-09
WO1994013287A1 (de) 1994-06-23
DK0675717T3 (da) 2000-02-28
DE59309733D1 (de) 1999-09-16
BG62475B1 (bg) 1999-12-30
MX9307644A (es) 1994-06-30
SK74095A3 (en) 1996-05-08
HU9501623D0 (en) 1995-08-28
JPH08504201A (ja) 1996-05-07
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11
HK1019003A1 (en) 2000-01-14
ATE183091T1 (de) 1999-08-15
AU5715294A (en) 1994-07-04
NO952207L (no) 1995-06-02
AU674378B2 (en) 1996-12-19
HUT71798A (en) 1996-02-28
CN1052400C (zh) 2000-05-17
ZA939065B (en) 1994-08-04
TW362973B (en) 1999-07-01
KR950703953A (ko) 1995-11-17
NO306930B1 (no) 2000-01-17
BG99700A (bg) 1996-04-30
ES2136725T3 (es) 1999-12-01
UA35604C2 (uk) 2001-04-16
PL309282A1 (en) 1995-10-02
RU2157685C2 (ru) 2000-10-20

Similar Documents

Publication Publication Date Title
FI952734A0 (fi) 2-Amino-6-A-propyyli-amino-4,5,6,7-tetrahydrobentsotiatsolin (Pramipexolin) käyttö lääkeaineena, jolla on antidepressiivinen vaikutus
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
FI950309A (fi) Proliiniamidijohdannaisia
FI943749A (fi) Taksaanijohdannaisten fosfono-oksimetyylieetterit
MY123193A (en) Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same
ATE143598T1 (de) Arzneimittellösung enhaltend derivate von fk506
MY124146A (en) Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
DK521685D0 (da) Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning
NO20000423L (no) Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
DE3880348T2 (de) N-substituierte alpha-mercaptomethylbenzenpropanamid-derivate, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
DK0587048T3 (da) Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ATE201023T1 (de) Ellipticinederivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
GB1433959A (en) Bis-thioureido benzene derivatives
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.
KR960021044A (ko) 세코노가노사이드를 포함하는 b형 간염 치료제